BACKGROUND & AIMS: In developed countries, reinfection after successful eradication of Helicobacter pylori appears unusual. High prevalences of H. pylori in developing countries may result in high reinfection rates. The aim of this study was to determine the rate of reinfection and ulcer recurrence in Chinese patients cured of H. pylori and duodenal ulcer disease. METHODS: One hundred eighty-four patients with duodenal ulcer disease shown by endoscopic examination (1 month) and 14C-urea breath test (3 months) after termination of treatment to have cleared their H. pylori were investigated. Patients were followed up by endoscopy (12 and 24 months) and breath test (6, 9, 12, 18, and 24 months). H. pylori status at endoscopic examination was determined by rapid urease, histology, and culture. In reinfected patients, random amplification of polymorphic DNA fingerprinting was used to compare isolates before and after therapy. RESULTS: Four patients were reinfected with H. pylori over 24 months (3 within 6 months and 1 at 24 months; average annual recurrence rate, 1.08%). Fingerprinting of isolates from 3 patients showed 1 patient (6 months) to have identical strains and the remainder to have nonidentical strains before and after treatment. Ulcer relapse occurred in 6 patients (4 H. pylori positive). CONCLUSIONS: Reinfection with H. pylori is rare in developing countries where treatment is effective.
BACKGROUND & AIMS: In developed countries, reinfection after successful eradication of Helicobacter pylori appears unusual. High prevalences of H. pylori in developing countries may result in high reinfection rates. The aim of this study was to determine the rate of reinfection and ulcer recurrence in Chinese patients cured of H. pylori and duodenal ulcer disease. METHODS: One hundred eighty-four patients with duodenal ulcer disease shown by endoscopic examination (1 month) and 14C-urea breath test (3 months) after termination of treatment to have cleared their H. pylori were investigated. Patients were followed up by endoscopy (12 and 24 months) and breath test (6, 9, 12, 18, and 24 months). H. pylori status at endoscopic examination was determined by rapid urease, histology, and culture. In reinfected patients, random amplification of polymorphic DNA fingerprinting was used to compare isolates before and after therapy. RESULTS: Four patients were reinfected with H. pylori over 24 months (3 within 6 months and 1 at 24 months; average annual recurrence rate, 1.08%). Fingerprinting of isolates from 3 patients showed 1 patient (6 months) to have identical strains and the remainder to have nonidentical strains before and after treatment. Ulcer relapse occurred in 6 patients (4 H. pylori positive). CONCLUSIONS: Reinfection with H. pylori is rare in developing countries where treatment is effective.
Authors: Annelie Lundin; Britta Björkholm; Ilya Kupershmidt; Magnus Unemo; Peter Nilsson; Dan I Andersson; Lars Engstrand Journal: Infect Immun Date: 2005-08 Impact factor: 3.441
Authors: Michael Kotiw; Megan Johnson; Manisha Pandey; Scott Fry; Stuart L Hazell; Hans J Netter; Michael F Good; Colleen Olive Journal: Clin Vaccine Immunol Date: 2011-12-28
Authors: Jung D Oh; Helene Kling-Bäckhed; Marios Giannakis; Jian Xu; Robert S Fulton; Lucinda A Fulton; Holland S Cordum; Chunyan Wang; Glendoria Elliott; Jennifer Edwards; Elaine R Mardis; Lars G Engstrand; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2006-06-20 Impact factor: 11.205
Authors: Asish K Mukhopadhyay; Jin-Yong Jeong; Daiva Dailidiene; Paul S Hoffman; Douglas E Berg Journal: J Bacteriol Date: 2003-05 Impact factor: 3.490
Authors: Marios Giannakis; Swaine L Chen; Sherif M Karam; Lars Engstrand; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2008-03-10 Impact factor: 11.205